Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetes
about
PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseasesLack of thrombospondin 1 and exacerbation of choroidal neovascularizationDiabetes and retinal vascular dysfunction.Expression of pigment epithelium-derived factor and thrombospondin-1 regulate proliferation and migration of retinal pigment epithelial cells.Thrombospondin-2 Expression During Retinal Vascular Development and Neovascularization.Thrombospondin-1-Based Antiangiogenic Therapy.Inflammatory cytokine-specific alterations in retinal endothelial cell function.Functional and molecular characterization of ex vivo cultured epiretinal membrane cells from human proliferative diabetic retinopathy.Thrombospondin-1 Deficiency Exacerbates the Pathogenesis of Diabetic Retinopathy.PEDF expression regulates the proangiogenic and proinflammatory phenotype of the lung endothelium.Therapies using anti-angiogenic peptide mimetics of thrombospondin-1.The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?Matricellular protein thrombospondins: influence on ocular angiogenesis, wound healing and immuneregulation.Negative regulators of angiogenesis: important targets for treatment of exudative AMD.Osteopontin and other regulators of angiogenesis and fibrogenesis in the vitreous from patients with proliferative vitreoretinal disorders.Feeding sugar to tumors: with a supplement of miR?PEDF expression affects retinal endothelial cell proangiogenic properties through alterations in cell adhesive mechanisms.PEDF Expression Affects the Oxidative and Inflammatory State of Choroidal Endothelial Cells.Role of Inflammation in Diabetic Retinopathy.
P2860
Q27026916-7A75EE4B-BE9E-4DBC-8B39-D6298D99D9EFQ34122564-17539596-8315-49EF-A0FF-33FB20441EA7Q35017752-C3CF918C-1022-43E8-ADF9-5A8D07C8B83EQ35294211-C1FC9D5B-F3E5-4135-9768-E6504376E230Q35623995-60E0BE5A-5CAA-456B-948B-446EE35327ECQ36417463-8BD9D05E-20B6-4B25-96B8-DD39C2F9637CQ37150614-75622E73-8922-40E9-8A06-168B538A9AB5Q37250409-D85C3128-88CB-4367-A398-E614BA1A70FEQ37283355-0F3F9EB3-0D8F-46C4-BD17-DEF321828713Q37656043-D13794A9-07A3-4D02-A78A-B5FE967C79D0Q37963916-838401D2-249A-48EB-B977-253DF515061BQ38103913-E1C27ED9-E175-488D-884C-90B327E4720EQ38190108-8DAFBA2A-3AEA-44DC-8C05-E181782B9750Q39416208-99619BFE-FFFC-4218-B5B4-A57B34C70ED4Q42469702-E6D19CD8-82ED-4FBF-B9E6-57F27D29444AQ42588858-5E6E42B3-D964-4B2D-8465-E0FC23C4E796Q47876851-8C1216F0-540C-4EEE-AF34-08F5D279D045Q49918278-3B5112AC-8FF6-4A13-91C6-572E5EF899B7Q52642996-8BD7E889-1F8C-48BF-94F7-2420EE211226
P2860
Modulation of thrombospondin 1 and pigment epithelium-derived factor levels in vitreous fluid of patients with diabetes
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Modulation of thrombospondin 1 ...... luid of patients with diabetes
@ast
Modulation of thrombospondin 1 ...... luid of patients with diabetes
@en
type
label
Modulation of thrombospondin 1 ...... luid of patients with diabetes
@ast
Modulation of thrombospondin 1 ...... luid of patients with diabetes
@en
prefLabel
Modulation of thrombospondin 1 ...... luid of patients with diabetes
@ast
Modulation of thrombospondin 1 ...... luid of patients with diabetes
@en
P2093
P2860
P1433
P1476
Modulation of thrombospondin 1 ...... luid of patients with diabetes
@en
P2093
Christine M Sorenson
Justin L Gottlieb
Nader Sheibani
Shoujian Wang
P2860
P304
P356
10.1001/ARCHOPHTHALMOL.2009.53
P407
P577
2009-04-01T00:00:00Z